PMNOC Proceedings:

  • DEXILANT (dexlansoprazole): Takeda Canada v Apotex
  • TRAJENTA (linagliptin): Boehringer Ingelheim v Pharmascience
  • LUMIGAN RC (bimatoprost): Allergan v Juno Pharmaceuticals
  • JUBLIA (efinaconazole): Bausch Health and Valeant v Apotex

Judicial Reviews:

  • SIMLANDI, HUMIRA (adalimumab): AbbVie v Minister of Health and JAMP Pharma

For complete details about these proceedings, click here.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.